The blood-brain barrier

Vivian Imbriotis | May 25, 2026

The blood-brain barrier is an interface that seperates the brain from the blood. It impedes the influx of almost all but non-essential molecules from blood \(\to\) brain.

Structure

  1. Endothelium: no fenestrae, numerous tight junctions between each other, many mitochondria
  2. Basement membrane
  3. Foot processes of astrocytes: ensheath vessels, contain enzymes e.g. MAO

Barrier function

  • Endothelial cell tight junctions \(\to\) minimize paracellular diffusion of hydrophilic substances
  • Enzymes in astrocytes and endothelium degrade substances or alter them to be water-soluble \(\to\) cannot cross endothelium

Transport function

  • Metabolic substrate, vitamins, electrolytes and antibodies are transported in controlled manner
  • Passive diffusion \(\to\) must be very small and/or very lipid-soluble e.g. O2, CO2, water
  • Facilitated diffusion e.g. glucose via GLUT1 channels
  • Active transport e.g. of calcium
  • Pinocytosis e.g. of antibodies

Areas with no blood-brain barrier

  • The circumventricular organs. Either sensors that sample plasma or excretors of a hormone
  • VOLT \(\to\) osmoceptor
  • Pineal gland \(\to\) secretes melatonin
  • Posterior pituitary \(\to\) secretes ADH
  • Chemoreceptor trigger zone \(\to\) chemoreceptor that integrates vomiting signals

Drug features that facilitate movement across BBB

  • Small MW, highly lipophilic
  • High \(\Delta\)C \(\to\) low protein binding, low Vd, low potency (\(\therefore\)large dose), cerebral metabolism of drug)
  • Substrate for active transport (e.g. lithium masquarades as sodium, valproate as lactate)